Buy Crypto Markets Spot FuturesIOST Earn Event Center Rewards Hub

ProQR Therapeutics N.V. (PRQR)

NASDAQ

$1.87

$-0.09

(-4.64%)

Previous Close: ⁦$1.94⁩

Market Closed

ProQR Therapeutics N.V. (PRQR) Live Price Chart

Last updated: ⁦2026-09-13 21:07:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

ProQR Therapeutics N.V. (PRQR) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.87, with a market capitalization of $262.48M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.33 to $3.10. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$262.48M
Open	$1.97
Day's High	$27.60
Day's Low	$0.53
Previous Close	$1.94
Volume	565.87K
Average Volume	1.11M
P/E Ratio	--
52-Week High	$3.10
52-Week Low	$1.33
Dividend Yield	--
Earnings Date	--

ProQR Therapeutics N.V. (PRQR) Latest Closing Stock Price

ProQR Therapeutics N.V. (PRQR) last closed at $1.94 as of 2026-09-11 23:59:00, unchanged from the previous close of $1.94.

During the latest regular trading session, PRQR traded between $0.53 and $27.60, with a volume of 565.87K shares. The closing price was near the lower end and near the lower end of its 52-week range.

ProQR Therapeutics N.V. (PRQR) 7-Day Stock Price Change

Over the past seven days, ProQR Therapeutics N.V. (PRQR) moved from $2.15 to $1.87, representing a decline of 13.26% ($0.28).

The stock traded between $1.85 and $2.22 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 560.59 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

PRQR 52-Week Price Position

Position in Range: 30.2%

52W Low$1.33

52W High$3.10

PRQR is currently trading at $1.87, placing it 30.2% of the way from its 52-week low of $1.33 to its 52-week high of $3.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is ProQR Therapeutics N.V. (PRQR)?

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

ProQR Therapeutics N.V. Information

Employees	187
Exchange	NASDAQ
Company Website	https://www.proqr.com

How to Buy ProQR Therapeutics N.V. (PRQR) Stock on MEXC

Eligible investors can buy real shares of ProQR Therapeutics N.V. (PRQR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PRQR and Place Your Order

Open the RealStocks trading page and search for PRQR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is ProQR Therapeutics N.V. (PRQR) stock price today?

ProQR Therapeutics N.V. (PRQR) is currently trading at $ 1.87, down 3.87% ($0.07) from the previous close of $ 1.94. Intraday prices update in real time during regular trading hours.

2.Is PRQR stock going up or down today?

As of 2026-09-11 23:59:00, PRQR is trading at $ 1.87, down 3.87% ($0.07) from its previous close of $ 1.94. The stock has traded between $ 0.53 and $ 27.60 during today’s regular session. Past price movements do not guarantee future results.

3.What is PRQR pre-market price?

As of 2026-09-11 23:59:00, PRQR is trading at $ 1.95 in pre-market trading, up 0.26% ($0.01) from the previous close of $ 1.94. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PRQR after-hours price?

As of 2026-09-11 23:59:00, PRQR is trading at $ 1.91 in after-hours trading, down 1.60% ($0.03) from the regular-session close of $ 1.94. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PRQR stock trading now?

PRQR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PRQR sit relative to its 52-week high and low?

Over the past 52 weeks, PRQR has traded between a low of $ 1.33 and a high of $ 3.10. At $ 1.87, the stock is positioned 30.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is ProQR Therapeutics N.V. in?

ProQR Therapeutics N.V. (PRQR) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is ProQR Therapeutics N.V.'s market capitalization and where is it listed?

ProQR Therapeutics N.V. is listed on the NASDAQ exchange with a market capitalization of $ 262.48M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PRQR valued in terms of P/E ratio and EPS?

PRQR trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does ProQR Therapeutics N.V. pay a dividend?

ProQR Therapeutics N.V. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.